12:00 AM
 | 
Oct 20, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Genous Bio-engineered R stent: Post-marketing study data

In a post-marketing study of Genous in 236 patients with predominantly complex lesions, the TLR rate was 8% and the MACE rate was 14% at 1 year. One patient experienced acute...

Read the full 134 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >